The Media Line Staff
An existing drug could mitigate the serious effects of the coronavirus.
Research at the Hebrew University in Jerusalem has shown that Fenofibrate (Tricor), an FDA-approved drug that has been on the market since 1975, prevents the progression of the virus by breaking down the fatty buildup in the lung cells of patients, allowing them to recover from lung infections caused by the coronavirus in a matter of days. The evidence even showed that there was zero mortality among these patients, according to the university.
Wake up to the Trusted Mideast News source Mideast Daily News Email
By subscribing, you agree to The Media Line terms of use and privacy policy.